Common side effects of Amturnide include: hyperkalemia and hypokalemia.  See below for a comprehensive list of adverse effects.
Aliskiren:Rare (less than 0.1%): HypotensionAmlodipine:Common (1% to 10%): palpitationsUncommon (0.1% to 1%): Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, hypotension, peripheral ischemia, postural hypotension, tachycardia, vasculitisRare (less than 0.1%): Myocardial infarction, anginaHydrochlorothiazide:Frequency not reported: Cardiac arrhythmias (including ventricular ectopy and complete AV heart block), hypotension, orthostatic hypotension (more common in the elderly)
Aliskiren:Common (1% to 10%): RashRare (less than 0.1%): Angioedema (involving the face, hands, or whole body)Postmarketing reports: Severe cutaneous adverse reactions (including Stevens Johnson syndrome and toxic epidermal necrolysis)Amlodipine:Common (1% to 10%): Rash, erythematous rashUncommon (0.1% to 1%): Angioedema, erythema multiforme, increased sweating, maculopapular rash, pruritusRare (less than 0.1%): Alopecia, dermatitis, skin discoloration, skin dryness, urticaria, lichen planus, telangiectasiaHydrochlorothiazide:Rare (less than 0.1%): Erythema annular centrifugum, acute eczematous dermatitis, morbilliform and leukocytoclastic vasculitis, phototoxic dermatitisFrequency not reported: Subacute cutaneous lupus erythematosus like reaction
Amlodipine:Postmarketing reports: Gynecomastia
Aliskiren:Common (1% to 10%): Diarrhea, abdominal pain, dyspepsia, gastroesophageal reflux (these side effects appear to be dose related)Postmarketing reports: Nausea, vomitingAmlodipine:Common (1% to 10%): Nausea, dysphagia, abdominal painUncommon (0.1% to 1%): Anorexia, constipation, diarrhea, dry mouth, dyspepsia, flatulence, gingival hyperplasia, pancreatitis, vomitingRare (less than 0.1%): Gastritis, increased appetite, loose stools, taste perversion, dysgeusiaHydrochlorothiazide:Uncommon (0.1% to 1%): Nausea, vomiting, diarrhea
Amlodipine:Uncommon (0.1% to 1%): Micturition disorder, micturition frequency, nocturiaRare (less than 0.1%): Dysuria, polyuria
Amlodipine:Uncommon (0.1% to 1%): Leukopenia, purpura, thrombocytopeniaHydrochlorothiazide:Rare (less than 0.1%): Immune-complex hemolytic anemia, aplastic anemia, thrombocytopenia
Common (1% to 10%): Occasional elevations (greater than 150% from baseline) in ALT (SGPT)Amlodipine:Postmarketing reports: Jaundice and hepatic enzyme elevations (mostly consistent with cholestasis or hepatitis)-Some cases were severe enough to require hospitalization Hydrochlorothiazide:Rare (less than 0.1%): Interstitial nephritis
Aliskiren:Frequency not reported: Angioedema (face, hands, and body) with or without respiratory symptomsPostmarketing reports: AngioedemaAmlodipine:Uncommon (0.1% to 1%): Allergic reactionHydrochlorothiazide:Uncommon (0.1% to 1%): Rash Rare (less than 0.1%): Anaphylaxis
Very rare (less than 0.01%): Hot flushesFrequency not reported: Edema, peripheral edemaAliskiren:Uncommon (0.1% to 1%): Elevated uric acid, gout, renal stonesPostmarketing reports: Peripheral edema, hyponatremiaUric acid increase greater than 50% from baseline was more commonly observed in patients treated with aliskiren / amlodipine / hydrochlorothiazide (4.7%) compared with the dual combinations (0.4 to 2.8%).  Gout was less commonly observed (0.3% in aliskiren / amlodipine / hydrochlorothiazide treated patients) and renal stones were not reported.Amlodipine:Uncommon (0.1% to 1%): Hyperglycemia, thirst, weight loss, weight gainVery rare (less than 0.01%): Acute porphyria exacerbationFrequency not reported: New-onset diabetes Hydrochlorothiazide:Very common (10% or more): Mild hypokalemia (decrease of 0.5 mEq/L) occurs in up to 50% of patients, and may predispose patients to cardiac arrhythmiasCommon (1% to 10%): Metabolic alkalosis, hyponatremia, hypomagnesemia, hypercalcemia, hyperglycemia, elevated serum uric acid levelsVery rare (less than 0.01%): Hot flushesFrequency not reported: Edema, peripheral edema, glucose intolerance, a potentially deleterious effect on the lipid profile (i.e., increased serum cholesterol)
Hydrochlorothiazide:Common (1% to 10%): Rash that is histologically identical to subacute cutaneous lupusFrequency not reported: Allergic vasculitis, hemolytic anemia
Uncommon (0.1% to 1%): Malaise, painFrequency not reported: FatigueAliskiren:Frequency not reported: Headache, dizziness, fatigue, episodes of tonic-clonic seizures with loss of consciousnessAmlodipine:Common (1% to 10%): Headache, dizziness, somnolenceUncommon (0.1% to 1%): Hypoesthesia, paresthesia, peripheral neuropathy, postural dizziness, syncope, tinnitus, tremorRare (less than 0.1%): MigraineHydrochlorothiazide:Frequency not reported: Cerebrovascular insufficiency associated with hydrochlorothiazide-induced plasma volume contraction, cognitive and neurologic impairment (i.e., confusion, somnolence, feeling dazed)- Symptoms resolved following discontinuation of hydrochlorothiazide.
Uncommon (0.1% to 1%): Asthenia, rigorsAmlodipine:Common (1% to 10%): MyalgiaUncommon (0.1% to 1%): Arthralgia, arthrosis, muscle crampsRare (less than 0.1%): Hypertonia, muscle weakness, twitching, ataxiaHydrochlorothiazide:Uncommon (0.1% to 1%): Myalgias, chills, muscle spasms, preservation of mineral bone density in older patients
Amlodipine:Uncommon (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye painRare (less than 0.1%): Abnormal visual accommodation, xerophthalmiaHydrochlorothiazide:Frequency not reported: Transient blurred vision, acute transient myopia, acute angle-closure glaucoma, xanthopsia
Rare (less than 0.1%): ParosmiaFrequency not reported: Tinnitus
Amlodipine:Rare (less than 0.1%): Interstitial nephritisHydrochlorothiazide:Rare (less than 0.1%): Renal insufficiency, renal failure, renal dysfunction, interstitial nephritis
Aliskiren:Frequency not reported: Nasopharyngitis, upper respiratory tract infection, coughAmlodipine:Common (1% to 10%): EpistaxisUncommon (0.1% to 1%): DyspneaRare (less than 0.1%): Coughing, rhinitisPostmarketing reports: Pulmonary edema was reported during a study of patients with NYHA Class III or IV heart failure without clinical symptoms or objective evidence of underlying ischemic disease.Hydrochlorothiazide:Frequency not reported: Acute noncardiogenic pulmonary edema (these cases are thought to be due to idiosyncrasy or a hypersensitivity mechanism)
Bloating or swelling of the face, arms, hands, lower legs, or feet
rapid weight gain
tingling of the hands or feet
unusual weight gain or loss
Dizziness
Blurred vision
confusion
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
sweating
unusual tiredness or weakness
Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
Acid or sour stomach
fever
headache
itching skin
lack or loss of strength
muscle aches
rash
sore throat
stomach discomfort, upset, or pain
stuffy or runny nose